MHC class II gene silencing in trophoblast cells is caused by inhibition of CIITA expression

American Journal of Reproductive Immunology

Volumn 40, Issue 6, 1998, Pages 385-394

  Morris, Ann C ^a   Riley, James L ^b   Fleming, William H ^c   Boss, Jeremy M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Gene regulation; IFN ; Maternal fetal tolerance; MHC class II; Trophoblasts

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; GENE SILENCING; GENETIC TRANSDUCTION; HISTOCOMPATIBILITY GENE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TROPHOBLAST;

EID: 0032414264     PISSN: 10467408     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1998.tb00423.x     Document Type: Article

References (65)

1. Heyborne K, Fu Y-X, Nelsen A, Farr A, O'Brien R, Born W: Recognition of trophoblasts by γδ T cells. J Immunol 1994; 153:2918-2926.
2. Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG: Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 1993; 151:4562-4573.
3. Morii T, Nishikawa K, Saito S, Encomoto M, Ito A, Kural N, Shimoyama T, Ichuo M, Narita N. T-cell receptors are expressed but down regulated on intradecidual T lymphocytes. Am J Reprod Immunol 1993; 29:1-4.
4. Raghupathy R: Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997; 18:478-482.
5. Altman DJ, Schneider SL, Thompson DA, Cheng H-L, Tomasi TB: A transforming growth factor β2 (TGF β2)-like immunosuppressive factor in amniotic fluid and localization of TGF-β2 mRNA in the pregnant uterus. J Exp Med 1990; 172:1391-1401.
6. Crainie M, Guilbert L, Wegmann TG: Expression of novel cytokine transcripts in the murine placenta. Biol Reprod 1990; 43:999-1005.
7. Delassus S, Coutinho GC, Saucier C, Darche S, Kourilsky P: Differential cytokine expression in maternal blood and placenta during murine gestation. J Immunol 1994; 152:2411-2420.
8. Faulk WP, Sanderson AR, Temple A: Distribution of MHC antigens in human placental chorionic villi. Trans Proc 1977; 9:1379-1384.
9. Jenkinson EJ, Searle RF: Ia expression on the developing mouse embryo and placenta. J Reprod Immunol 1979; 1:3.
10. Sunderland CA, Naiem M, Mason DY, Redman CWG, Stirrat GM: The expression of major histocompatibility antigens by human chorionic villi. J Reprod Immunol 1981; 3:323-331.
11. Billington WD, Bell SC: Immunoregulatory factors in pregnancy: Essential or irrelevant in the maintenance of the fetoplacental allograft? Placenta Suppl. 1982; 4:13-23.
12. Peyman JA, Hammond GL: Localization of IFN-γ receptor in first trimester placenta to trophoblasts but lack of stimulation of HLA-DRA, -DRB, or invariant chain mRNA expression by IFN-γ. J Immunol 1992; 149:2675-2680.
13. Goodfellow PN, Barnstable CJ, Bodmer WF, Snary D, Crumpton MJ: Expression of HLA system antigens on placenta. Transplantation 1976; 22:595-603.
14. Kawata M, Parnes JR, Herzenberg LA: Transcriptional control of HLA A,B,C antigens in human placental cytotrophoblasts isolated using trophoblast and HLA specific monoclonal antibodies and the fluorescence activated cell sorter. J Exp Med 1984; 160:633-651.
15. Ellis SA, Sargent IL, Redman WG, McMichael AJ: Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line. Immunology 1986; 59:595-601.
16. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R: A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990; 248:220-223.
17. Ellis SA, Palmer MS, McMichael AJ: Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule. J Immunol 1990; 144:731-735.
18. Hunt JS, Orr HT: HLA and maternal-fetal recognition. Fed Am Soc Exp Biol 1992; 6:2344-2348.
19. Hunt JS: Immunobiology of pregnancy. Curr Opin Immunol 1992; 4:591-596.
20. Chiang MH, Main EK: Nuclear regulation of HLA class I genes in human trophoblasts. Am J Reprod Immunol 1994; 32:167.
21. Kappes D, Strominger JL: Human class II major histocompatibility complex genes and proteins. Annu Rev Biochem 1988; 57:991-1028.
22. Glimcher LH, Kara CJ: Sequences and factors: A guide to MHC class II transcription. In Paul WE, Garrison Fathman C, Metzger H (eds). Annual Reviews of Immunology. Palo Alto, Annual Reviews Inc., 1992, pp 13-50.
23. Pober JS, Collins T, Gimbone MA Jr, Cotran RS, Gitlin JD, Fiers W, Clayberber C, Krensky AM, Burakoff SJ, Reiss CS: Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature 1983; 305:726-729.
24. Buck L, Axel R: A novel multigene family may encode odorant receptors: A molecular basis for odor recognition. Cell 1991; 65:175-187.
25. Zuckermann FA, Head JR: Expression of MHC antigens on murine trophoblast and their modulation by interferon. J Immunol 1986; 137:846.
26. Peyman JA, Nelson PJ, Hammond GL: HLA-DR genes are silenced in human trophoblasts and stimulation of signal transduction pathways does not circumvent IFN-γ unresponsiveness. Trans Proc 1992; 24:470.
27. Labarrere C, Althabe O, Telenta M: Chronic villitis of unknown aetiology in placentae of idiopathic small for gestational age infants. Placenta 1982; 3:309.
28. Althabe O, Labarrere C: Chronic villitis of unknown aetiology and intrauterine growth retarded infants of normal and low ponderal index. Placenta 1985; 6:369.
29. Labarrere CA, Faulk WP: MHC class II reactivity of human villous trophoblast in chronic inflammation of unestablished etiology. Transplantation 1990; 50:812-816.
30. Vassiliadis S, Tsoukatos D, Athanassakis I. Interferon-induced class II expression at the spongiotrophoblastic zone of the murine placenta is linked to fetal rejection and developmental abnormalities. Acta Physiol Scand 1995; 151:485-395.
31. Mattsson R, Mattsson A, Holmdahl R, Scheynius A, Van der Meide PH: In vivo treatment with interferon-gamma during early pregnancy in mice induces strong expression of major histocompatibility complex class I and II molecules in uterus and decidua but not in extra-embryonic tissues. Biol Reprod 1992; 46:1176-1186.
32. Boss JM, Strominger JL: Regulation of a transfected human class II major histocompatibility complex gene in human fibroblasts. Proc Natl Acad Sci USA 1986; 83:9139-9143.
33. Tsang SY, Nakanishi M, Peterlin BM: B-cell-specific and interferon-gamma-inducible regulation of the HLA-DR alpha gene. Proc Natl Acad Sei USA 1988; 85:8598-8602.
34. Wright KL: Conserved upstream sequences of human class II major histocompatibility genes enhance expression of class II genes in wild-type but not mutant B-cell lines. Proc Natl Acad Sci USA 1988; 85:8186-8190.
35. Sloan JH, Hasegawa SL, Boss JM: Single base pair substitutions within the HLA-DRA gene promoter separate the functions of the X1 and X2 boxes. J Immunol 1992; 148:2591-2599.
36. Hasegawa SL, Boss JM: Two distinct B cell factors bind the HLA-DRA X box region and recognize different subsets of MHC class II promoters. Nucleic Acids Res 1991 ; 19:6269-6276.
37. Kara CJ, Glimcher LH: In vivo footprinting of MHC class II genes: Bare promoters in the bare lymphocyte syndrome. Science 1991; 252:709-712.
38. Moreno CS, Emery P, West JE, Durand B, Reith W, Mach B, Boss JM: Purified X2BP cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome. J Immunol 1995; 155:4313-4321.
39. Riley JL, Westerheide SD, Price JA, Brown JA, Boss JM: Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 1995; 2:533-543.
40. Steimle V, Siegrist C-A, Mottet A, Lisowska-Grospierre B, Mach B: Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 1994; 265:106-108.
41. Chang C-H, Fontes JD, Peterlin BM, Flavell RA: Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J Exp Med 1994; 180:1367-1374.
42. Silacci P, Mottet A, Steimle V, Reith W, Mach B: Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J Exp Med 1994; 180:1329-1336.
43. Zhou H, Glimcher LH: Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 1995; 2:545-553.
44. Lee YJ, Benveniste EN: Stat1 alpha expression is involved in IFN-gamma induction of the class II transactivator and class II MHC genes. J Immunol 1996; 157:1559.
45. Epstein MA, Achong BG, Barr YM, Zajac B, Henle G, Henle W: Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). J Natl Cancer Inst 1966; 37:547-559.
46. Riley JL, Boss JM: Class II MHC transcriptional mutants are defective in higher order complex formation. J Immunol 1993; 151:6942-6953.
47. Steimle V, Otten LA, Zufferey M, Mach B: Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 1993; 75:135-146.
48. Chin K-C, Mao C, Skinner C, Riley JL, Wright KL, Moreno CS, Stark GR, Boss JM, Ting JP-Y: Molecular analysis of G1B and G3A IFN-γ mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity 1994; 1:687-697.
49. Darnell JE Jr, Kerr LM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264:1415.
50. Greenland AC, Morales MO, Viviano BL, Yan H, Krolewski J, Schreiber RD: Stat recruitment by tyrosine-phosphorylated cytokine receptors: An ordered reversible affinity-driven process. Immunity 1995; 2:677.
51. Greenlund AC, Farrar MA, Viviano L, Schreiber RD: Ligand-induced IFN-γ receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). Eur Mol Biol Organ J 1994; 13:1591.
52. Meraz MA, White JM, Sheehan KCF, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M, Schreiber RD: Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996; 84:431.
53. Wright KL, Chin K-C, Linhoff M, Skinner C, Li G, Boss JM, Stark GR, Ting JP-Y: CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo. Proc Natl Acad Sci USA 1998; 95:6267-6272.
54. Chang C, Flavell RA: Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J Exp Med 1995; 765:765-767.
55. Hobart M, Ramassar V, Goes N, Urmson J, Halloran PF: IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo. J Immunol 1997; 158:4260.
56. Martin BK, Chin K-C, Olsen JC, Skinner CA, Dey A, Ozato K, Ting JP-Y: Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity 1997; 6:581-600.
57. Gobin SJP, Peijnenburg A, Keijsers V, van den Elsen PJ: Site a is crucial for two routes of IFN-γ-induced MHC class I transactivation: The ISRE-mediate route and a novel pathway involving CIITA. Immunity 1997; 6:601-611.
58. Steimle V, Durand B, Emmanuele B, Zufferey M, Hadam MR, Mach B, Reith W: A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev 1995; 9:1021-1032.
59. Reith W, Satola S, Herreo-Sanchez C, Amaldi I, Lisowska-Grospierre B, Griscelli C, Hadam MR, Mach B: Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell 1988; 53:897-906.
60. Herrero-Sanchez C, Reith W, Silacci P, Mach B: The DNA-binding defect observed in major histocompatibility complex class II regulatory mutants concerns only one member of a family of complexes binding to the X boxes of class II promoters. Mol Cell Biol 1992; 12:4076-4083.
61. Stimac E, Urieli-Shoval S, Kempin S, Pious D: Defective HLA DRA X box binding in the class II transactive transcription factor mutant 6.1.6 and in cell lines from class II immunodeficient patients. J Immunol 1991; 146:4398-4405.
62. Durand B, Sperisen P, Emery P, Barras E, Zufferey M, Mach B, Reith W: RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. Eur Mol Biol Organ J 1997; 16:1045-1055.
63. Muhlethaler-Mottet A, Otten LA, Steimle V, Mach B: Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. Eur Mol Biol Organ J 1997; 16:2851-2860.
64. Athanassakis-Vassiliadis I, Galanopolos VK, Grigoriou M, Papamatheakis J: Induction of class II MHC antigen expression on the murine placenta by 5-azacytidine correlates with fetal abortion. Cell Immunol 1990; 128:438-449.
65. Gustafsson E, Arvola M, Brunsberg U, Mattsson A, Mattsson R: Lack of detectable major histocompatibility complex class U Aβ-chain messenger ribonucleic acid in placentas of interferon-γ- and 5-azacytidine-treated mice. Biol Reprod 1997; 57:715-722.